X-linked Charcot-Marie-Tooth disease.

Area of Science:

• Neurology
• Genetics
• Cell Biology

Background:

• X-linked Charcot-Marie-Tooth disease (CMT1X) is a common hereditary neuropathy.
• It results from mutations in the GJB1 gene, encoding connexin32 (Cx32).
• Cx32 gap junctions are crucial for axonal homeostasis in Schwann cells and oligodendrocytes.

Purpose of the Study:

• To review the clinical and pathological features of CMT1X.
• To discuss the role of Cx32 mutations in disease pathogenesis.
• To highlight the current therapeutic landscape and unmet needs.

Main Methods:

• Literature review of CMT1X studies.
• Analysis of clinical, neurophysiological, and pathological findings.
• Examination of GJB1 mutations and Cx32 function.

Main Results:

• CMT1X presents with progressive muscle atrophy, weakness, and sensory deficits, with CNS involvement.
• Over 400 GJB1 mutations identified, many impairing Cx32 gap junction function.
• Animal models show Cx32 loss in Schwann cells causes demyelinating neuropathy.

Conclusions:

• CMT1X pathogenesis involves impaired Cx32 gap junction function and axonal integrity.
• Understanding Cx32's role is key to developing targeted therapies.
• Effective treatments for CMT1X are currently lacking.